Abacus Life, Inc. (ABL)
(Delayed Data from NSDQ)
$10.33 USD
+0.03 (0.29%)
Updated Aug 27, 2024 03:59 PM ET
After-Market: $10.46 +0.13 (1.26%) 7:58 PM ET
1-Strong Buy of 5 1
F Value F Growth B Momentum F VGM
Price, Consensus and EPS Surprise
ABL 10.33 +0.03(0.29%)
Will ABL be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ABL based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ABL
Wall Street Analysts Predict a 32.72% Upside in Abacus Life, Inc. (ABL): Here's What You Should Know
GoHealth (GOCO) Reports Q2 Loss, Lags Revenue Estimates
ABL: What are Zacks experts saying now?
Zacks Private Portfolio Services
FinWise Bancorp (FINW) Tops Q2 Earnings Estimates
Abacus Life, Inc. (ABL) Stock Jumps 20.3%: Will It Continue to Soar?
Other News for ABL
Hold Rating on Abbott Laboratories Amid NEC Litigation Uncertainties
Abacus Life (ABL) Shares Cross Below 200 DMA
Abacus Life and Lorisco Life Announce Launch of PREADISAN? to Improve Health Predictions
Abacus Life, Lorisco Life announce launch of PREADISAN
Abacus Life (ABL) Gets a Buy from Piper Sandler